➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Medtronic
Colorcon
Mallinckrodt
McKinsey

Last Updated: August 10, 2020

DrugPatentWatch Database Preview

Ritodrine hydrochloride - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for ritodrine hydrochloride and what is the scope of freedom to operate?

Ritodrine hydrochloride is the generic ingredient in three branded drugs marketed by Abraxis Pharm, Hospira, and Astrazeneca, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for ritodrine hydrochloride.

Summary for ritodrine hydrochloride
Recent Clinical Trials for ritodrine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Assiut UniversityPhase 3
Assiut UniversityPhase 4
Assiut UniversityN/A

See all ritodrine hydrochloride clinical trials

Medical Subject Heading (MeSH) Categories for ritodrine hydrochloride

US Patents and Regulatory Information for ritodrine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER ritodrine hydrochloride INJECTABLE;INJECTION 071438-001 Jan 22, 1991 DISCN No No   Start Trial   Start Trial   Start Trial
Astrazeneca YUTOPAR ritodrine hydrochloride INJECTABLE;INJECTION 018580-002 Sep 27, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
Abraxis Pharm RITODRINE HYDROCHLORIDE ritodrine hydrochloride INJECTABLE;INJECTION 071189-001 Jul 23, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira RITODRINE HYDROCHLORIDE ritodrine hydrochloride INJECTABLE;INJECTION 071618-001 Feb 28, 1991 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ritodrine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca YUTOPAR ritodrine hydrochloride INJECTABLE;INJECTION 018580-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Astrazeneca YUTOPAR ritodrine hydrochloride TABLET;ORAL 018555-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Astrazeneca YUTOPAR ritodrine hydrochloride INJECTABLE;INJECTION 018580-002 Sep 27, 1984   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Express Scripts
Colorcon
Moodys
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.